Why is NovoCure Limited (NVCR) being discussed these days?
NovoCure Limited (NVCR) revealed the results this week of a clinical trial that put its unique electronic cancer therapy to the test. As a result of this, quotes increased by almost 50% on Tuesday; by Wednesday, the share was valued at $186. NVCR closed at $186.00 at the close of the last trading day, falling […]
